2021 annual financial data
Alaunos Therapeutics 2021 Operating margin
Direct answer
Operating margin was -19,484.67%.
Operating income was -77,549,000 USD and net income was -78,751,000 USD.
Operating cash flow was -61,468,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 398,000 USD
- Operating income
- -77,549,000 USD
- Net income
- -78,751,000 USD
- Operating cash flow
- -61,468,000 USD